Literature DB >> 33934917

Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.

Krista Wilkinson1, Christiaan H Righolt2, Lawrence J Elliott3, Sergio Fanella4, Salaheddin M Mahmud5.   

Abstract

A comprehensive review of observational pertussis vaccine effectiveness (VE) studies is needed to update gaps from previous reviews. We conducted a systematic review of VE and duration of protection studies for the whole-cell (wP) and acellular (aP) pertussis vaccines and conducted a formal meta-analysis using random effects models. Evidence continues to suggest that receipt of any pertussis vaccine confers protection in the short-term against disease although this protection wanes rapidly for aP vaccine. We detected significant heterogeneity in pooled estimates due, in part, to factors such as bias and confounding which may be mitigated by study design. Our review of possible sources of heterogeneity may help interpretation of other VE studies and aid design decisions in future pertussis VE research.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bordetella pertussis; Pertussis vaccine; Systematic review and meta-analysis; Vaccine effectiveness; Whooping cough

Mesh:

Substances:

Year:  2021        PMID: 33934917     DOI: 10.1016/j.vaccine.2021.04.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   4.169


  6 in total

1.  Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy.

Authors:  Pauline Versteegen; Axel A Bonačić Marinović; Pieter G M van Gageldonk; Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Vaccines (Basel)       Date:  2022-04-28

2.  Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen.

Authors:  Kenji Okada; Yuho Horikoshi; Naoko Nishimura; Shigeki Ishii; Hiroko Nogami; Chikako Motomura; Isao Miyairi; Naoki Tsumura; Toshihiko Mori; Kenta Ito; Shinichi Honma; Kensuke Nagai; Hiroshi Tanaka; Toru Hayakawa; Chiharu Abe; Kazunobu Ouchi
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

3.  Long-lived immunity to genetically detoxified pertussis vaccines.

Authors:  Camille Locht
Journal:  EClinicalMedicine       Date:  2021-07-06

Review 4.  Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host.

Authors:  Thomas Belcher; Violaine Dubois; Alex Rivera-Millot; Camille Locht; Françoise Jacob-Dubuisson
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria.

Authors:  Khedidja Tahar Djebbar; Mounia Allouache; Salim Kezzal; Fouzia Benguerguoura; Chafia TouilBoukoffa; Ines Zidi; Rachida Raache; Hadda-Imene Ouzari
Journal:  Vaccines (Basel)       Date:  2022-06-06

Review 6.  Novel Strategies to Inhibit Pertussis Toxin.

Authors:  Katharina Ernst
Journal:  Toxins (Basel)       Date:  2022-03-03       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.